PMID: 2115190Jan 1, 1990Paper

The outcome of community acquired pneumonia treated on the intensive care unit

Respiratory Medicine
M AlkhayerB D Harrison

Abstract

Eighteen patients with community acquired pneumonia required intensive care for severe or progressive hypoxaemia, rising arterial carbon dioxide tension or respiratory arrest, and 17 received intermittent positive pressure ventilation. Thirteen survived to leave hospital and 12 are long term survivors. Ventilation was started within 4 days of admission in all cases and was continued for up to 34 days; six patients required ventilation for over 3 weeks. The most common medical complication was renal failure. The most common iatrogenic complication was pneumothorax. We believe that all the hypoxic patients would have died from their hypoxia had it not been corrected. We estimated that up to 5% of patients admitted with community acquired pneumonia need intensive care. This study demonstrates the effectiveness of such care, which is multidisciplinary, demanding, and may need to be prolonged.

References

Jun 9, 1979·British Medical Journal·J F NunnJ Singaraya
May 1, 1985·The Journal of Infection·M A WoodheadA D Macrae
Jan 1, 1985·Scandinavian Journal of Infectious Diseases·A OrtqvistJ A Nilsson
Feb 25, 1983·JAMA : the Journal of the American Medical Association·E W HookD R Schaberg
May 1, 1980·Anaesthesia·I S Petheram, M A Branthwaite
Apr 24, 1980·The New England Journal of Medicine·G E ThibaultE R Skinner
May 1, 1964·Annals of Internal Medicine·R AUSTRIAN, J GOLD

❮ Previous
Next ❯

Citations

Sep 28, 2001·International Journal of Antimicrobial Agents·D Honeybourne
Oct 1, 1994·Respiratory Medicine·H M MayB D Harrison
Apr 6, 1996·BMJ : British Medical Journal·S R Johnson, I D Pavord
Nov 20, 2001·Thorax·UNKNOWN British Thoracic Society Standards of Care Committee
Aug 29, 2006·Critical Care : the Official Journal of the Critical Care Forum·Mark WoodheadJon G Ayres
Mar 19, 2002·Emerging Infectious Diseases·Wen-Chien KoVictor L Yu
Apr 3, 2014·Critical Care : the Official Journal of the Critical Care Forum·Andrew P WaldenUNKNOWN ESICM/ECCRN GenOSept Investigators
Jun 1, 1997·Anaesthesia and Intensive Care·H Y So
Nov 1, 1992·Respiratory Medicine·M A Woodhead

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.